All Simon Drysdale articles
-
NewsUganda launches Phase I clinical study of Bundibugyo virus disease vaccine
A Phase I clinical study has been launched evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV). The study is part of an international effort to develop vaccines against Ebola virus species for which no licensed vaccines are currently available.